Safety and Performance Evaluation of a New Catheter Range for Lead Implantation At Interventricular Septum

NCT06453850 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2025-03-06

No results posted yet for this study

Summary

The purpose of the clinical investigation is to evaluate the safety of the FLEXIGO delivery catheter for transvenous pacing lead implantation.

Conditions

  • Bradycardia
  • Cardiac Resynchronization Therapy
  • Left Bundle Branch Area Pacing

Interventions

DEVICE

Use of FLEXIGO delivery catheter

Use of FLEXIGO delivery catheter for implantation of ventricular pacing lead

Sponsors & Collaborators

  • MicroPort CRM

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-14
Primary Completion
2025-07-31
Completion
2026-12-31

Countries

  • Portugal
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06453850 on ClinicalTrials.gov